Full Text
The Effect Of FDA Risk Evaluation Mitigation Strategies On Utilization Of Selected Drugs Using Data From Two National Surveys

Abstract

Authors

J.A. Thompson P.C. Heaton C.M. Kelton

Back to Volume 16, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×